Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
4.230
-0.060 (-1.40%)
At close: Jan 2, 2026, 4:00 PM EST
4.228
-0.002 (-0.04%)
After-hours: Jan 2, 2026, 5:08 PM EST
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $103.82 million as of January 2, 2026. Its market cap has decreased by -58.90% in one year.
Market Cap
103.82M
Enterprise Value
-4.51M
1-Year Change
-58.90%
Ranking
Category
Stock Price
$4.23
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $103.82M, a decrease of -41.26%. That is a compound annual growth rate of -30.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 103.82M | -1.40% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |